Liquid Biopsy for Precision Oncology Summit West Coast leaderboard
  • Friday, November 20, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

SmartLab Exchange Europe 2027 Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 952

Abzena signs licensing deal for ThioBridge antibody drug conjugate linker technology

Jan 23, 2017
Abzena has entered into a licensing agreement with with a San Diego-based biopharmaceutical firm for its novel site-specific ThioBridge antibody drug conjugate (ADC) linker technology.…
Read More...

Symbiomix Therapeutics Submits New Drug Application to US FDA for Solosec

Jan 21, 2017
Symbiomix, a biopharmaceutical company bringing innovative medicines to market for prevalent gynecological infections, announced submission of a new drug application (NDA) for Solosec™…
Read More...

Ethypharm Acquires Martindale Pharma in the UK

Jan 21, 2017
Ethypharm announced that it has signed a definitive agreement to acquire Martindale Pharma. Martindale Pharma is a leading UK-based specialty pharmaceutical company providing…
Read More...

Evotec Enters into an Integrated Drug Discovery Collaboration with Asahi Kasei Pharma (Japan)

Jan 21, 2017
Evotec AG announced it has entered into an integrated drug discovery collaboration on an ion channel target with Asahi Kasei Pharma Corporation, a wholly owned subsidiary of Asahi Kasei…
Read More...

Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid

Jan 20, 2017
Eli Lilly and Company and CoLucid Pharmaceuticals, Inc. announced an agreement for Lilly to acquire CoLucid for $46.50 per share or approximately $960 million. This all-cash transaction…
Read More...

Takeda and Ovid Therapeutics Announce Clinical Development and Commercialization Collaboration for…

Jan 19, 2017
Takeda Pharmaceutical Company Limited and Ovid Therapeutics Inc., a privately-held biopharmaceutical company committed to developing medicines that transform the lives of people with…
Read More...

MilliporeSigma Opens Production Facility Exclusively for Meglumine in Spain

Jan 19, 2017
MilliporeSigma announced the opening of a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component…
Read More...

Progenra Discovers Novel Immune Oncology Drug

Jan 18, 2017
Progenra, Inc. announced a new immune-oncology drug whose mechanism differs from available cancer immunotherapies Opdivo and Keytruda. The findings, published by Progenra with Dr. Wayne…
Read More...

Evotec and MaRS Innovation Establish Strategic Partnership to Launch Fibrocor Therapeutics

Jan 18, 2017
Evotec AG and MaRS Innovation today announced the launch of Fibrocor Therapeutics LP, a Toronto-based company focused on developing first-in-class therapeutics targeting fibrotic…
Read More...

Brazil issues first license for sale of a cannabis-based drug

Jan 17, 2017
Brazilian healthcare regulator Anvisa on Monday said it had issued the country's first license for sale of a cannabis-based drug in the country after years of legal wrangling with…
Read More...
Previous 1 … 950 951 952 953 954 … 966 Next
Oligonucleotide-based Therapeutics Summit
LEAP HR: Life Sciences Europe
3rd Annual TRP Target Selection & Drug Design Summit
2nd Structure-Based Drug Design Summit San Diego
Liquid Biopsy for Precision Oncology Summit West Coast
2nd Non-Opioid Pain Therapeutics Summit
Muscular Disorders Drug Development Summit
Amylin-Based Therapeutics Summit
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Antigen-Specific Immune Tolerance Summit
7th Operationalize Expanded Access Programs Summit
Viral Vector Process Development & Manufacturing Summit
SmartLab Exchange Europe 2027
8th RNAi-Based Therapeutics Summit
17th World ADC London
PFS & Injectable Drug Devices Europe
Ophthalmic Drug Delivery Summit
Obesity & Weight Loss Drug Development Summit West
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Biomarker Operations & Biospecimen Management
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • OBI Pharma Signs $2 Billion ADC Deal with Novartis
  • Erasca and Bristol Myers Squibb Partner on Pancreatic Cancer Treatment
  • GSK Wins FDA Approval for Nelkarmi in Advanced Lung Cancer
  • OXB Partners with Aura Biosciences for Phase 3 Cancer Drug Development
  • Skylark Bio Advances Hearing Loss Gene Therapy to Younger Children

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Cell Therapy Safety in Autoimmune Disease

7th Operationalize: Expanded Access Programs Summit East…

As AI and ICH M15 Transform Drug Development, Industry…

Industry Leaders Explore the Future of RNA Therapeutics…

Direct RNA Binding Emerges as a Powerful Approach for…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.